An early window of efficacy for anti-Aβ antibody revealed by
4.8
$ 16.50
In stock
(155)
Product Description
Titer and isotype of anti-Ab antibodies produced in mice immunized with
A Therapeutic Antibody Targeting BACE1 Inhibits Amyloid-β Production in Vivo
A surrogate marker for very early-stage tau pathology is detectable by molecular magnetic resonance imaging
A TNF receptor 2 agonist ameliorates neuropathology and improves cognition in an Alzheimer's disease mouse model
Biomolecules, Free Full-Text
Full article: Monoclonal antibodies against β-amyloid (Aβ) for the treatment of Alzheimer's disease: the Aβ target at a crossroads
Anti-Ubiquitin Antibody [Ubi-1] (A85456)
IJMS, Free Full-Text
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody, Alzheimer's Research & Therapy
